Sanofi ADR
USUSDSanofi ADR (VI:SANO) — Biotechnology: Pharmaceutical Preparations. Numero di borse in cui sono quotate le azioni della società: 6. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'azienda
- Sito web
- sanofi.com
- Settore
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede centrale
- PARIS, France
- Amministratore delegato
- Paul Hudson
- Dipendenti
- 106 566
- Fondata
- 2004
- Quotata dal
- 04.10.2017 (VI:SANO)
- Azioni in circolazione
- 1.22 Mld al 2025-12-31
- Flottante
- 2.16 Mld
- Capitalizzazione di mercato
- 98.67 Mld USD
- Insider
- 0%
- Investitori istituzionali
- 8.02%
- Settore (SIC)
- Pharmaceutical Preparations
- Forma giuridica
- QVPB
- ISIN
- FR0000120578
- LEI
- 549300E9PC51EN656011
- Payout ratio
- 0%
- FCF
- 10.8 Mld EUR
- Debito
- 18.7 Mld EUR1.0 anni di FCF
- Serie di dividendi
- 23 a.
- Utili, FCF e dividendi pagati — per i 12 mesi fino a 31.12.2025 (l'ultimo rapporto dell'azienda).
Descrizione
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Borse e ticker
| Borsa | Ticker | Valuta | Prezzo | Tipo |
|---|---|---|---|---|
| US USA Stocks | SNYNF OTC | USD | 79.9382 +2.14% | azioni ordinarie |
| LSE London Stock Exchange | 0O59 IOB | EUR | 71.63 +0.72% | azioni ordinarie |
| MI Borsa Italiana (Milan) | 1SAN secondaria | EUR | 71.64 +0.90% | azioni ordinarie |
| PA Euronext Paris | SAN principale | EUR | 71.52 +0.83% | azioni ordinarie |
| VI Vienna Stock Exchange | SANO secondaria | EUR | 71.3 +1.03% | azioni ordinarie |
| XETRA Xetra | SNW secondaria | EUR | 71.78 -1.21% | azioni ordinarie |
Dividendi
Sanofi ADR (SANO) paga dividendi una volta all'anno. Negli ultimi 12 mesi, sono stati pagati 4.12 EUR per azione (pagamenti: 1). Questo rappresenta circa il 5.78% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 04.05.2027. Storia dei dividendi ininterrotta: 23 anni.
| Data ex | Pagamento | Importo | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-05-05 | 2026-05-07 | 4.1200 EUR | 5.8/5.8 % | annuale | VI:SANO |
| 2025-05-12 | 2025-05-14 | 3.9200 EUR | 5.5/5.5 % | annuale | VI:SANO |
| 2024-05-13 | — | 3.7600 EUR | 5.3/10.3 % | annuale | VI:SANO |
| 2023-05-30 | — | 3.5600 EUR | 5.0/5.0 % | annuale | VI:SANO |
| 2022-05-06 | — | 3.3300 EUR | 4.7/4.7 % | annuale | VI:SANO |
Notizie di questa settimana
Ancora nessuna notizia dal sito della società.
Principali azionisti
| Detentore | Quota | Azioni | Data del rapporto |
|---|---|---|---|
| Dodge & Cox Inc. | 10.54% | 28.09 Mln | 2026-06-30 |
| Dodge & Cox Funds-Dodge… | 7.84% | 20.9 Mln | 2026-06-30 |
| Morgan Stanley | 4.02% | 10.7 Mln | 2026-06-30 |
| Fisher Asset Management,… | 3.99% | 10.63 Mln | 2026-06-30 |
| Bank of America Corporat… | 3% | 8.01 Mln | 2026-06-30 |
| Invesco Ltd. | 2.55% | 6.8 Mln | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.47% | 6.57 Mln | 2026-06-30 |
| Mondrian Investment Part… | 2.07% | 5.52 Mln | 2026-06-30 |
| Brandes Investment Partn… | 1.55% | 4.14 Mln | 2026-06-30 |
| AIM Sector Funds (Invesc… | 1.51% | 4.03 Mln | 2026-04-30 |
| Federated Hermes, Inc. | 1.44% | 3.85 Mln | 2026-06-30 |
| Boston Partners | 1.44% | 3.84 Mln | 2026-06-30 |
| VANGUARD STAR FUNDS-Vang… | 1.31% | 15.85 Mln | 2026-07-31 |
| Putnam ETF Trust-Putnam… | 1.26% | 3.36 Mln | 2026-05-31 |
| VANGUARD TAX-MANAGED FUN… | 0.87% | 10.53 Mln | 2026-06-30 |
| iShares Trust-iShares Co… | 0.67% | 8.11 Mln | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.63% | 1.67 Mln | 2026-06-30 |
| AMERICAN MUTUAL FUND | 0.59% | 1.58 Mln | 2026-06-30 |
| American Century Capital… | 0.37% | 976 561 | 2026-06-30 |
| Bridge Builder Trust-Bri… | 0.36% | 967 100 | 2026-06-30 |
| Fidelity Concord Street… | 0.35% | 4.24 Mln | 2026-07-31 |
| VanEck ETF Trust-VanEck… | 0.35% | 938 561 | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.33% | 4.04 Mln | 2026-06-30 |
| iShares Trust-iShares MS… | 0.32% | 3.89 Mln | 2026-08-31 |
| Capital World Growth & I… | 0.3% | 3.67 Mln | 2026-06-30 |
| -Victory Pioneer Core Eq… | 0.3% | 799 487 | 2026-06-30 |
| Fidelity Covington Trust… | 0.3% | 797 184 | 2026-08-31 |
| NEW PERSPECTIVE FUND | 0.29% | 3.56 Mln | 2026-06-30 |
| Federated Hermes Eqy. Fd… | 0.29% | 3.48 Mln | 2026-07-31 |
| Bridge Builder Trust-Bri… | 0.29% | 3.44 Mln | 2026-06-30 |
| Pacer Advisors, Inc. | 0.1% | 1.16 Mln | 2026-06-30 |
| Generali Investments Cee… | 0% | 29 339 | 2026-06-30 |
| Paradigm Asset Managemen… | 0% | 19 200 | 2026-06-30 |
| Gamma Investing LLC | 0% | 58 | 2026-06-30 |
| L'Oréal | — | — | — |
